That’s the question The Real Deal’s reporters and editors ask as each year shifts into gear. Who gets deals done, gets money moving into projects, gets shovels going? Those big players in the market ...

Apple’s latest immersive video for Vision Pro users is coming this week. It’s called Real Madrid: The Weight of Greatness and takes viewers inside the famous football club. Apple’s 180-degree ...

The Federal Bureau of Investigation announced plans to buy nationwide access to a network of license plate readers, saying it will award contracts to one or more vendors that can offer “near real time ...

The company that operates online learning system Canvas said it struck a deal with hackers to delete the data they pilfered in a cyberattack that created chaos for students, many of them in the middle ...

May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...

When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real time, FDA Commissioner Marty Makary, MD, MPH, reached for an analogy from ...

As global temperatures rise, data centers for artificial intelligence are creating “heat islands” that could have significant impacts on communities and their surrounding environments in the years to ...

Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.